Characteristic | All (n = 1014) | Non-ICU (n = 809) | ICU (n = 205) | p-value |
---|---|---|---|---|
Laboratory findings | ||||
 White blood cell count (× 109/L)a | 7.7 ± 4.5 (1.1–42.9) | 6.9 ± 3.3 (1.1–26.6) | 10.3 ± 6.7 (1.4–42.9) |  ≤ 0.0005 |
White blood cell count (× 109/L) (No (%))a | ||||
  < 4 | 150 (14.8%) | 127 (15.7%) | 23 (11.3%) |  ≤ 0.0005 |
 4–10 | 651 (64.2%) | 555 (68.6%) | 96 (46.8%) |  |
  > 10 | 213 (21%) | 127 (15.7%) | 86 (41.9%) |  |
 Neutrophil count (× 109/L)b | 3.4 ± 3.2 (0.01–9.7) | 3.2 ± 3.3 (0.01–9.6) | 4.9 ± 3.6 (0.1–9.7) |  ≤ 0.0005 |
 Lymphocyte count (× 109/L)b | 1.3 ± 1.6 (0.3–8.4) | 1.2 ± 1.6 (0.34–8.4) | 1.3 ± 1.5 (0.3–6.2) | 0.278 |
Lymphocyte count (× 109/L) (No (%))a | ||||
  < 1.0 | 195 (19.2%) | 131 (16.2%) | 64 (31.2%) | 0.138 |
  ≥ 1.0 | 819 (80.8%) | 678 (83.8%) | 141 (68.8%) |  |
 Hemoglobin (g/dL)b | 12.2 ± 2.3 (3.7–17.4) | 12.5 ± 2.2 (4.5–17.4) | 11.3 ± 2.3 (3.7–16.4) |  ≤ 0.0005 |
 Platelet count (× 109/L)b | 285.3 ± 130.6 (8–861) | 285.6 ± 123.1 (8–802) | 290.2 ± 153.3 (24–861) | 0.850 |
Platelet count (× 109/L) (No (%))a | ||||
  < 100 | 80 (7.9%) | 57 (7.1%) | 23 (11.2%) | 0.128 |
  ≥ 100 | 934 (92.1%) | 752 (92.9%) | 182 (88.8%) |  |
 Alanine aminotransferase (U/L)b | 55.9 ± 144.3 (3.8–2,465) | 43.2 ± 84 (3.8–1,534) | 92.6 ± 227.6 (5.7–2,465) |  ≤ 0.0005 |
 Aspartate aminotransferase (U/L)b | 80.1 ± 432.8 (3–10,252) | 66.8 ± 463.5 (3–10,252) | 109.5 ± 283 (7.3–2,870) |  ≤ 0.0005 |
Aspartate aminotransferase (U/L) (No (%))a | ||||
  < 40 | 704 (69.4%) | 592 (73.2%) | 112 (54.6%) |  ≤ 0.0005 |
  ≥ 40 | 310 (30.6%) | 217 (26.8%) | 93 (45.4%) |  |
 Potassium (mmol/L)b | 4.4 ± 0.7 (2.8–8.1) | 4.4 ± 0.7 (2.8–8.1) | 4.5 ± 0.7 (2.9–7.5) | 0.132 |
 Sodium (mmol/L)b | 137.9 ± 5.7 (57.8–163) | 137.7 ± 5.4 (57.8–163) | 138.8 ± 6.5 (127–163) | 0.960 |
 Creatinine (μmol/L)b | 89 ± 96.5 (5.2–927) | 84.5 ± 92.7 (5.7–927) | 92.5 ± 81.4 (5.2–645) | 0.081 |
Creatinine (μmol/L) (No (%)a | ||||
  ≤ 107 | 833 (82.1%) | 673 (83.2%) | 160 (78.1%) | 0.002 |
  > 107 | 181 (17.9%) | 136 (16.8%) | 45 (21.9%) |  |
 Creatinine kinase (U/L)b | 257.6 ± 821 (2.2–9,716) | 204 ± 673.4 (2.2–9,716) | 497.4 ± 1,314 (9–9,716) | 0.098 |
Creatinine kinase (U/L) (No (%))a | ||||
  ≤ 198 | 680 (67.1%) | 557 (68.8%) | 123 (60.2%) | 0.015 |
  > 198 | 334 (32.9%) | 252 (31.2%) | 82 (39.8%) |  |
 Lactate dehydrogenase (U/L)c | 16.4 ± 20.1 (0.2–96) | 14.2 ± 18.7 (0.2–96) | 22.6 ± 24.2 (2.1–96) |  ≤ 0.0005 |
Lactate dehydrogenase (U/L) (No (%))a | ||||
  ≤ 280 | 549 (54.1%) | 479 (59.2%) | 70 (34.2%) |  ≤ 0.0005 |
  > 280 | 465 (45.9%) | 330 (40.8%) | 135 (65.8%) |  |
 C-reactive protein (mg/L)b | 16.4 ± 20.1 (0.2–96) | 14.2 ± 18.7 (0.2–96) | 22.6 ± 24.2 (2.1–96) | 0.092 |
 Ferritin (µg/L)c | 845.6 ± 3,430 (2–49,813) | 502.9 ± 860.5 (4.4–7,945) | 1,647 ± 5,270 (2–42,969) |  ≤ 0.0005 |
 ESR (mm/hour)b | 49 ± 35.8 (1–139) | 47.9 ± 35.2 (1–139) | 54.3 ± 38.7 (1–130) | 0.552 |
Chest CT imagesa | ||||
 Normal | 295 (29.1%) | 283 (35%) | 12 (5.8%) |  ≤ 0.0005 |
 Abnormal bilateral lung | 427 (42.1%) | 285 (35.2%) | 142 (69.3%) |  |
 Abnormal right lung | 95 (9.4%) | 79 (9.8%) | 16 (7.8%) |  |
 Abnormal left lung | 110 (10.9%) | 96 (11.9%) | 14 (6.8%) |  |
 No radiography data available | 87 (8.5%) | 66 (8.1%) | 21 (10.2%) |  |